Nancy Villa

Assistant Research Professor

  • 400 Citations
  • 12 h-Index
20042020
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Nancy Villa is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Myxoma virus Medicine & Life Sciences
Poxviridae Medicine & Life Sciences
Yeasts Medicine & Life Sciences
Progesterone Receptors Medicine & Life Sciences
Oncolytic Viruses Medicine & Life Sciences
Graft vs Host Disease Medicine & Life Sciences
Vaccinia virus Medicine & Life Sciences
Neoplasms Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2020

  • 400 Citations
  • 12 h-Index
  • 14 Article
  • 3 Review article
  • 1 Chapter
  • 1 Short survey

Ex Vivo Virotherapy with Myxoma Virus to Treat Cancer

Villa, N., Franco, L. S. & McFadden, D., Jan 1 2020, Methods in Molecular Biology. Humana Press Inc., p. 95-110 16 p. (Methods in Molecular Biology; vol. 2058).

Research output: Chapter in Book/Report/Conference proceedingChapter

Myxoma virus
Viruses
Neoplasms
Leukocytes
Rabbits

Virotherapy as Potential Adjunct Therapy for Graft-Vs-Host Disease

Villa, N. & McFadden, D., Dec 1 2018, In : Current Pathobiology Reports. 6, 4, p. 247-263 17 p.

Research output: Contribution to journalReview article

Open Access
Graft vs Host Disease
Oncolytic Viruses
Myxoma virus
Hematopoietic Stem Cell Transplantation
Oncolytic Virotherapy
12 Citations (Scopus)

Ex Vivo Oncolytic Virotherapy with Myxoma Virus Arms Multiple Allogeneic Bone Marrow Transplant Leukocytes to Enhance Graft versus Tumor

Lilly, C. L., Villa, N., Lemos de Matos, A., Ali, H. M., Dhillon, J. K. S., Hofland, T., Rahman, M., Chan, W., Bogen, B., Cogle, C. & McFadden, D., Mar 1 2017, In : Molecular Therapy - Oncolytics. 4, p. 31-40 10 p.

Research output: Contribution to journalArticle

Myxoma virus
Oncolytic Virotherapy
Multiple Myeloma
Leukocytes
Arm
9 Citations (Scopus)

Ex vivo virotherapy with myxoma virus does not impair hematopoietic stem and progenitor cells

Villa, N., Bais, S., Chan, W. M., Meacham, A. M., Wise, E., Rahman, M., Moreb, J. S., Rosenau, E. H., Wingard, J. R., McFadden, D. & Cogle, C. R., Mar 1 2016, In : Cytotherapy. 18, 3, p. 465-480 16 p.

Research output: Contribution to journalArticle

Myxoma virus
Hematopoietic Stem Cells
Virus Diseases
Hematologic Neoplasms
Transplants
4 Citations (Scopus)

Therapeutics for graft-versus-host disease: From conventional therapies to novel virotherapeutic strategies

Villa, N., Rahman, M., McFadden, D. & Cogle, C. R., Mar 1 2016, In : Viruses. 8, 3, 85.

Research output: Contribution to journalReview article

Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Myxoma virus
Oncolytic Viruses
Transplants

Projects 2017 2020